April 6, 2012 — Crux Biomedical announced that a recently completed pivotal trial of its Crux Vena Cava Filter (VCF) System with bi-directional retrieval was presented at the 2012 Society of Interventional Radiology (SIR) Annual Scientific Meeting, March 24-29, in San Francisco. Vena cava filters are designed to trap blood clots that can lead to potentially fatal pulmonary embolisms (PE) among patients at risk. In the study, deployment and retrieval each were achieved with a 98 percent success rate.

April 6, 2012 — Positron Corp. announced the approval of its Nuclear Regulatory Commission (NRC) manufacturing and distribution license amendment for the company's radiopharmaceutical manufacturing facility in Crown Point, Ind.

April 6, 2012 — Boston Scientific Corp. announced results from a quantitative coronary angiographic (QCA) analysis of the incidence of longitudinal stent deformation in the PERSEUS and PLATINUM randomized clinical trials, comprising more than 2,400 patients across three distinct coronary stent platforms: the Platinum Chromium Element platform (Ion Paclitaxel-Eluting Stent System [Taxus Element] and Promus Element Everolimus-Eluting Stent System), the Xience V Promus Everolimus-Eluting Stent System, and the Taxus Express Paclitaxel-Eluting Stent System.

April 5, 2012 —Maquet and Siemens Healthcare announced they will collaborate closely to introduce a combined system for diagnostics and surgical procedures. The first systems will be delivered and installed starting May 2012.